A.M. Risitano

Non-HSCT treatment

A. Bacigalupo

HSCT for AA

E. Angelucci

Management of iron overload

S. Marotta

Selected abstract: Aplasia Midollare Severa caratterizzata da gravi complicanze infettive trattata con terapia immunosoppressiva di prima linea (ATGAM) e terapia sequenziale con Eltrompobag

A. Picardi

Discussant

C. Girmenia

Fungal infections

I. Agreiter

Epidemiology of GITMO centers: a nurse survey

G. Gargiulo

Round table: management of AA patients and presentation of a GITMO nurse forum

A.P. Iori

PNH: to transplant or not to transplant?

F. Porta

Immunodeficiencies

F. Grimaldi

Selected abstract: A case of persistently low level of chimerism after HSCT for Severe Aplastic Anemia

M.T. Lupo-Stanghellini

Discussant

S. Soave

Nursing concerns in aplastic patients

V. De Cecco

Management of infectious risk in aplastic patients

L. Cappucciati

Counseling of aplastic patients and their families

A. Pagliuca

The "FCC platform" and T-cell repleted haploidentical HSCT

A.M. Raiola

aGvHD: standard and experimental therapies

A. Rambaldi

MSC and other cell-based therapies for aGvHD

A. Olivieri

Chronic GvHD: treatment and long-term impact

E. Ceresoli

Selected abstract: L'Anemia Aplastica Idiopatica acquisita del giovane adulto: Case Report a Confronto

D. Pastore

Discussant

G. La Nasa

Chimerism and DLI in HSCT for non-malignant disorders

F. Patriarca

Management of poor graft function

F. Onida

Management of endothelial complications

M.C. Della Casa

Selected abstract: A case of late onset endothelial complication after hemopoietic stem cell transplantation

G. Irrera

Discussant